Literature DB >> 21536796

Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient.

Carla P Coutinho1, Carla C C R de Carvalho, Andreia Madeira, Ana Pinto-de-Oliveira, Isabel Sá-Correia.   

Abstract

Chronic lung infection is the major cause of morbidity and premature mortality in cystic fibrosis (CF) patients. Bacteria of the Burkholderia cepacia complex are the most threatening pathogens in CF, and a better understanding of how these bacteria adapt to the CF airway environment and resist the host defense mechanisms and therapeutically administered antibiotics is crucial. To provide clues to the adaptive strategies adopted by Burkholderia cenocepacia during long-term colonization, we carried out a phenotypic assessment of 11 clonal variants obtained at the major Portuguese CF Center in Lisbon from sputa of the same CF patient during 3.5 years of colonization of the lungs, until the patient's death with cepacia syndrome. Phenotypic characterization included susceptibility assays against different classes of antimicrobials and characterization of cell motility, cell hydrophobicity and zeta potential, colony and cell morphology, fatty acid composition, growth under iron limitation/load conditions, exopolysaccharide production, and size of the biofilms formed. The results suggest the occurrence of clonal expansion during long-term colonization. For a number of the characteristics tested, no isolation time-dependent consistent alteration pattern could be identified. However, the values for antimicrobial susceptibility and swarming motility for the first B. cenocepacia isolate, thought to have initiated the infection, were consistently above those for the clonal variants obtained during the course of infection, and the opposite was found for the zeta potential. The adaptive strategy for long-term colonization, described here for the first time, involved the alteration of membrane fatty acid composition, in particular a reduction of the degree of fatty acid saturation, in the B. cenocepacia variants retrieved, along with the deterioration of pulmonary function and severe oxygen limitation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536796      PMCID: PMC3191963          DOI: 10.1128/IAI.01366-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex.

Authors:  Adam Baldwin; Eshwar Mahenthiralingam; Kathleen M Thickett; David Honeybourne; Martin C J Maiden; John R Govan; David P Speert; John J Lipuma; Peter Vandamme; Chris G Dowson
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center.

Authors:  Mónica V Cunha; Ana Pinto-de-Oliveira; Luís Meirinhos-Soares; Maria José Salgado; José Melo-Cristino; Susana Correia; Celeste Barreto; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

Review 3.  Living on a surface: swarming and biofilm formation.

Authors:  Natalie Verstraeten; Kristien Braeken; Bachaspatimayum Debkumari; Maarten Fauvart; Jan Fransaer; Jan Vermant; Jan Michiels
Journal:  Trends Microbiol       Date:  2008-09-03       Impact factor: 17.079

4.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

5.  Polyhydroxyalkanoate-accumulating bacterium isolated from soil of a sugar-cane plantation in Brazil.

Authors:  C O Brämer; P Vandamme; L F da Silva; J G Gomez; A Steinbüchel
Journal:  Int J Syst Evol Microbiol       Date:  2001-09       Impact factor: 2.747

6.  Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy.

Authors:  Andreia Madeira; Pedro M Santos; Carla P Coutinho; Ana Pinto-de-Oliveira; Isabel Sá-Correia
Journal:  Proteomics       Date:  2011-02-17       Impact factor: 3.984

7.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

Authors:  P Vandamme; B Holmes; M Vancanneyt; T Coenye; B Hoste; R Coopman; H Revets; S Lauwers; M Gillis; K Kersters; J R Govan
Journal:  Int J Syst Bacteriol       Date:  1997-10

8.  Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center.

Authors:  J H Leitão; S A Sousa; M V Cunha; M J Salgado; J Melo-Cristino; M C Barreto; I Sá-Correia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-04       Impact factor: 3.267

9.  Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  D W Reid; V Carroll; C O'May; A Champion; S M Kirov
Journal:  Eur Respir J       Date:  2007-05-15       Impact factor: 16.671

10.  [The clinical course of Burkholderia cepacia complex bacteria respiratory infection in cystic fibrosis patients].

Authors:  Susana Correia; Catarina Nascimento; Luísa Pereira; Mónica V Cunha; Isabel Sá-Correia; Celeste Barreto
Journal:  Rev Port Pneumol       Date:  2008 Jan-Feb
View more
  23 in total

1.  SNaPBceBcon: a Practical Tool for Identification and Genotyping of Burkholderia cepacia and Burkholderia contaminans.

Authors:  Ricardo Araujo; Rita Caramalho; Carla Coutinho; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

2.  Fosmidomycin decreases membrane hopanoids and potentiates the effects of colistin on Burkholderia multivorans clinical isolates.

Authors:  Rebecca J Malott; Chia-Hung Wu; Tracy D Lee; Trevor J Hird; Nathan F Dalleska; James E A Zlosnik; Dianne K Newman; David P Speert
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

3.  Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections.

Authors:  Charles C Traverse; Leslie M Mayo-Smith; Steffen R Poltak; Vaughn S Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-27       Impact factor: 11.205

Review 4.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

Review 5.  The art of persistence-the secrets to Burkholderia chronic infections.

Authors:  Eric R G Lewis; Alfredo G Torres
Journal:  Pathog Dis       Date:  2016-07-19       Impact factor: 3.166

6.  Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection.

Authors:  Ana S Moreira; Dalila Mil-Homens; Sílvia A Sousa; Carla P Coutinho; Ana Pinto-de-Oliveira; Christian G Ramos; Sandra C Dos Santos; Arsénio M Fialho; Jorge H Leitão; Isabel Sá-Correia
Journal:  Virulence       Date:  2016-09-21       Impact factor: 5.882

7.  SNaPBcen: a novel and practical tool for genotyping Burkholderia cenocepacia.

Authors:  Nadia Eusebio; Carla P Coutinho; Isabel Sá-Correia; Ricardo Araujo
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

Review 8.  Lipopolysaccharide modification in Gram-negative bacteria during chronic infection.

Authors:  Rita F Maldonado; Isabel Sá-Correia; Miguel A Valvano
Journal:  FEMS Microbiol Rev       Date:  2016-04-12       Impact factor: 16.408

9.  Rampant prophage movement among transient competitors drives rapid adaptation during infection.

Authors:  Christopher W Marshall; Erin S Gloag; Christina Lim; Daniel J Wozniak; Vaughn S Cooper
Journal:  Sci Adv       Date:  2021-07-16       Impact factor: 14.136

10.  Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.

Authors:  Carla P Coutinho; Sandra C Dos Santos; Andreia Madeira; Nuno P Mira; Ana S Moreira; Isabel Sá-Correia
Journal:  Front Cell Infect Microbiol       Date:  2011-12-02       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.